Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients.

Podcast Episode Summary

Introduction

Dr. Warrick Bishop is a practicing cardiologist and passionate heart health educator who hosts this podcast to help patients understand cardiac care through evidence-based information. In this episode, Dr. Bishop discusses two significant recent developments in cardiology: innovative smartphone technology for detecting atrial fibrillation and evolving treatment approaches for left main coronary artery disease. The episode focuses on how these advancements may change clinical practice and patient care in the near future.

Key Takeaways

• A Belgian research study successfully developed a smartphone app using photoplethysmography (analyzing facial blood flow patterns through camera images) to screen for atrial fibrillation in over 12,500 volunteers, detecting abnormalities in 1.1% of the population.

• The photoplethysmography technology shows approximately 95% accuracy compared to ECG, the gold standard for detecting atrial fibrillation.

• This smartphone screening technology may soon be available at points of service such as pharmacies and GP surgeries for opportunistic screening of patients over 65 with atrial fibrillation risk factors.

• The left main coronary artery is critical because sudden blockage affects two of the three major arteries supplying the heart, making treatment decisions particularly important.

• The EXCEL trial compared coronary artery bypass grafting versus stent placement for left main coronary artery disease in nearly 1,900 patients, with 20% eligible for randomization into either treatment option.

• Early results favored stenting over bypass surgery in terms of symptoms and reduced stroke risk, but the five-year data showed these early advantages had disappeared.

• At the five-year endpoint, both stenting and coronary artery bypass grafting produced similar outcomes with no significant detrimental signals in either group.

• Bypass grafting appears to offer better long-term longevity despite being more invasive initially, while stenting provides easier short-term relief but less durability beyond five years.

• Patients facing left main coronary artery disease treatment decisions can reasonably choose either stenting or bypass grafting for five-year outcomes, with the choice depending on personal preferences and consultation with their doctor.

• Long-term outcomes beyond five years remain unresolved, with future follow-up studies expected to provide data on 10-year comparisons between the two treatment approaches.